News wrap-up: This week's veterinary news, plus a new FDA approval

benevolente / stock.adobe.com

In light of One Health Awareness Month this January, we are raising awareness of the connection between human, animal, and environmental health while remaining committed to offering you the latest (and greatest) news coverage in the veterinary industry.

Here is a look at this week's highlights:

• Oakland Zoo in California celebrated its 100th anniversary and its significant achievements throughout the years including its expansion, pivotal role in animal welfare, and more.
• Antimicrobial stewardship is now securing its place in veterinary medicine after taking the human health world by storm. Check out more about it here.
• Sue Ettinger, DVM, DACVIM (Oncology), outlined differences to bear in mind when treating canine versus feline lymphoma.
• A Synchrony study revealed staggering findings regarding the lifetime cost of pet care to offer pet parents a better understanding of financial expectations and raise awareness of available flexible payment solutions.
• Kelly Cairns, DVM, DACVIM, MS, described the differences between feline neutrophilic and non-neutrophilic CCHS, plus she shared effective treatment approaches.
• The Food and Drug Administration (FDA) approved Frunevetmab injection (Zoetis; Solensia), which is the first monoclonal antibody for animals to receive FDA approval.
• In an episode of The Vet Blast Podcast, Chewy Health vice president, Mita Malhotra, highlighted the remarkable technological advancements the company developed in 2021.

Stay tuned on social media and dvm360.com for more veterinary news.